• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠肾部分切除术会损害缺血诱导的血管生成和后肢再灌注。

Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in rats.

作者信息

Jacobi J, Porst M, Cordasic N, Namer B, Schmieder R E, Eckardt K-U, Hilgers K F

机构信息

Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.

出版信息

Kidney Int. 2006 Jun;69(11):2013-21. doi: 10.1038/sj.ki.5000448.

DOI:10.1038/sj.ki.5000448
PMID:16641920
Abstract

Kidney disease is associated with increased cardiovascular morbidity, but underlying mechanisms are poorly understood. We tested the hypothesis that chronic renal insufficiency impairs angioadaptation in a rat model of hindlimb ischemia. Twenty male Sprague-Dawley rats (8 weeks old) underwent subtotal nephrectomy (5/6SNX) or sham surgery (each n=10). Ten weeks later, unilateral hindlimb ischemia was induced in all animals. Hindlimb perfusion was assessed by laser Doppler perfusion imaging and fluorescent microsphere injection studies 2 weeks after surgery. Ischemia-induced angiogenesis was measured by analyzing capillary density using CD31 immunofluorescence. Expression of vascular endothelial growth factor (VEGF), its receptors (VEGFRs) and inducible as well as endothelial nitric oxide (NO) synthase was measured by real-time reverse transcription-polymerase chain reaction. Laser Doppler hindpaw perfusion was significantly reduced in 5/6SNX compared to sham-operated animals. Impaired hindlimb re-perfusion in 5/6SNX vs control rats was confirmed by fluorescent microsphere injection studies (relative perfusion of ischemic vs non-ischemic limb: 68.9+/-6.4 vs 92.4+/-3.6%, P=0.005). Ischemic skeletal muscle neovascularization increased to a greater extent in sham-operated compared to 5/6SNX rats (69+/-8 vs 29+/-7%, P<0.05). VEGF and VEGFR-1/2 mRNA expression increased in ischemic hindlimbs of control rats, whereas no change or a decrease was observed in 5/6SNX. In contrast, inducible and endothelial NO synthase expression did not significantly differ between sham and 5/6SNX rats. Chronic renal insufficiency impairs angiogenesis and limb perfusion in a rat hindlimb ischemia model. Impaired angioadaptation may contribute to the poor prognosis of patients with renal failure suffering from peripheral arterial disease.

摘要

肾脏疾病与心血管疾病发病率增加相关,但潜在机制尚不清楚。我们在大鼠后肢缺血模型中检验了慢性肾功能不全损害血管适应性这一假说。20只雄性Sprague-Dawley大鼠(8周龄)接受了次全肾切除术(5/6SNX)或假手术(每组n = 10)。10周后,对所有动物进行单侧后肢缺血诱导。术后2周通过激光多普勒灌注成像和荧光微球注射研究评估后肢灌注。通过使用CD31免疫荧光分析毛细血管密度来测量缺血诱导的血管生成。通过实时逆转录聚合酶链反应测量血管内皮生长因子(VEGF)、其受体(VEGFRs)以及诱导型和内皮型一氧化氮(NO)合酶的表达。与假手术动物相比,5/6SNX组的激光多普勒后爪灌注显著降低。荧光微球注射研究证实5/6SNX组与对照大鼠相比后肢再灌注受损(缺血肢体与非缺血肢体的相对灌注:68.9±6.4% 对92.4±3.6%,P = 0.005)。与5/6SNX大鼠相比,假手术大鼠缺血骨骼肌的新血管形成增加幅度更大(69±8% 对29±7%,P<0.05)。对照大鼠缺血后肢中VEGF和VEGFR-1/2 mRNA表达增加,而在5/6SNX组中未观察到变化或有所降低。相反,假手术组和5/6SNX组大鼠之间诱导型和内皮型NO合酶表达无显著差异。慢性肾功能不全损害大鼠后肢缺血模型中的血管生成和肢体灌注。血管适应性受损可能导致患有外周动脉疾病的肾衰竭患者预后不良。

相似文献

1
Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in rats.大鼠肾部分切除术会损害缺血诱导的血管生成和后肢再灌注。
Kidney Int. 2006 Jun;69(11):2013-21. doi: 10.1038/sj.ki.5000448.
2
Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.在小鼠后肢缺血模型中,利用可溶性血管内皮生长因子受体进行腺病毒基因转移会损害血管生成和灌注。
Circulation. 2004 Oct 19;110(16):2424-9. doi: 10.1161/01.CIR.0000145142.85645.EA. Epub 2004 Oct 11.
3
The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia.大鼠后肢缺血时,渐进性或急性动脉闭塞对骨骼肌血流、动脉生成及炎症的影响。
J Vasc Surg. 2005 Feb;41(2):312-20. doi: 10.1016/j.jvs.2004.11.012.
4
Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis.冲击波治疗可促进后肢缺血模型中的血管生成并动员内源性 CD31/CD34 阳性内皮细胞:对血管生成和血管发生的影响。
J Thorac Cardiovasc Surg. 2013 Oct;146(4):971-8. doi: 10.1016/j.jtcvs.2013.01.017. Epub 2013 Feb 8.
5
Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats.吡格列酮对糖尿病大鼠缺血后肢缺氧诱导因子1α及血管内皮生长因子表达的影响
Eur Rev Med Pharmacol Sci. 2014;18(9):1307-14.
6
Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model.在大鼠后肢缺血模型中,内皮型一氧化氮合酶基因通过血管内皮生长因子表达诱导血管生成。
Circulation. 2003 Nov 4;108(18):2250-7. doi: 10.1161/01.CIR.0000093190.53478.78. Epub 2003 Oct 20.
7
Passive exercise using whole-body periodic acceleration enhances blood supply to ischemic hindlimb.被动全身周期性加速运动可增强缺血性后肢的血液供应。
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2872-80. doi: 10.1161/ATVBAHA.111.229773. Epub 2011 Sep 22.
8
Denervation in Femoral Artery-Ligated Hindlimbs Diminishes Ischemic Recovery Primarily via Impaired Arteriogenesis.股动脉结扎后肢的去神经支配主要通过受损的动脉生成减少缺血恢复。
PLoS One. 2016 May 13;11(5):e0154941. doi: 10.1371/journal.pone.0154941. eCollection 2016.
9
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.人肝细胞生长因子基因诱导大鼠和兔后肢缺血模型的治疗性血管生成:外周动脉疾病治疗的临床前研究
Gene Ther. 2001 Feb;8(3):181-9. doi: 10.1038/sj.gt.3301379.
10
In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.在2型糖尿病小鼠中,一种血管内皮生长因子(VEGF)激活转录因子可调节VEGF信号传导,并在后肢缺血后诱导治疗性血管生成。
Diabetes. 2007 Mar;56(3):656-65. doi: 10.2337/db06-0999.

引用本文的文献

1
Circulating Extracellular Vesicles as Putative Mediators of Cardiovascular Disease in Paediatric Chronic Kidney Disease.循环细胞外囊泡作为儿童慢性肾脏病中心血管疾病的潜在介质
J Extracell Vesicles. 2025 Mar;14(3):e70062. doi: 10.1002/jev2.70062.
2
Multiomic Analysis of Calf Muscle in Peripheral Artery Disease and Chronic Kidney Disease.外周动脉疾病和慢性肾脏病中小腿肌肉的多组学分析
Circ Res. 2025 Mar 28;136(7):688-703. doi: 10.1161/CIRCRESAHA.124.325642. Epub 2025 Feb 18.
3
Deletion of the aryl hydrocarbon receptor in endothelial cells improves ischemic angiogenesis in chronic kidney disease.
内皮细胞中芳香烃受体的缺失可改善慢性肾脏病中的缺血性血管生成。
Am J Physiol Heart Circ Physiol. 2024 Jan 1;326(1):H44-H60. doi: 10.1152/ajpheart.00530.2023. Epub 2023 Nov 3.
4
Activation of the Aryl Hydrocarbon Receptor in Muscle Exacerbates Ischemic Pathology in Chronic Kidney Disease.芳烃受体在肌肉中的激活会加剧慢性肾脏病的缺血性病变。
Circ Res. 2023 Jul 7;133(2):158-176. doi: 10.1161/CIRCRESAHA.123.322875. Epub 2023 Jun 16.
5
Prognostic Impact of Coronary Flow Reserve in Patients With CKD.慢性肾脏病患者冠状动脉血流储备的预后影响
Kidney Int Rep. 2022 Oct 8;8(1):64-74. doi: 10.1016/j.ekir.2022.10.003. eCollection 2023 Jan.
6
Comparison of the surgical resection and infarct 5/6 nephrectomy rat models of chronic kidney disease.慢性肾脏病手术切除和梗死 5/6 肾切除术大鼠模型的比较。
Am J Physiol Renal Physiol. 2022 Jun 1;322(6):F639-F654. doi: 10.1152/ajprenal.00398.2021. Epub 2022 Apr 4.
7
Modeling acute and chronic vascular responses to a major arterial occlusion.模拟对主要动脉闭塞的急性和慢性血管反应。
Microcirculation. 2021 Nov 15:e12738. doi: 10.1111/micc.12738.
8
Indoxyl sulfate impairs angiogenesis via chronic aryl hydrocarbon receptor activation.硫酸吲哚酚通过慢性芳香烃受体激活损害血管生成。
Am J Physiol Cell Physiol. 2021 Feb 1;320(2):C240-C249. doi: 10.1152/ajpcell.00262.2020. Epub 2021 Jan 6.
9
Microvascular disease in chronic kidney disease: the base of the iceberg in cardiovascular comorbidity.慢性肾脏病中的微血管疾病:心血管合并症中的冰山一角。
Clin Sci (Lond). 2020 Jun 26;134(12):1333-1356. doi: 10.1042/CS20200279.
10
Chronic kidney disease exacerbates ischemic limb myopathy in mice via altered mitochondrial energetics.慢性肾脏病通过改变线粒体能量代谢加剧小鼠缺血性肢体肌病。
Sci Rep. 2019 Oct 29;9(1):15547. doi: 10.1038/s41598-019-52107-7.